IL-33 plays important roles in type-2 innate immunity. After infection with the helminth Nippostrongylus brasiliensis and in response to IL-33, ILC2s expanded robustly and produced large amounts of IL-13, which led to goblet cell hyperplasia in the intestine and worm expulsion, even in the absence of adaptive immunity [ 7, 8 and 9]. IL-33-deficient selleckchem mice failed to clear worms due to a selective defect in ILC2-derived IL-13 [ 14]. Responsiveness of ILC2s to IL-33 was found to be controlled by Gfi1, a transcription factor which regulates ST2 expression at the surface of ILC2s

[ 15••]. Endogenous IL-33 has also been shown to be important for lung eosinophilic inflammation and IL-5 production by ILC2s, after infection with the nematode Pembrolizumab Strongyloides venezuelensis or intranasal administration of chitin, a polysaccharide constituent of many parasites and allergens [ 16•• and 17]. IL-33 is involved in the response to viral infection. For instance, IL-33/ST2 signaling has been found to be required for ILC2-dependent restoration of airway epithelial integrity after infection with influenza virus [18]. Activation of lung ILC2s by IL-33 was also shown to mediate influenza-induced airway

hyper-reactivity independently of adaptive immunity [19]. In addition, analysis of parainfluenza virus infection in IL-33-deficient mice revealed an essential role of IL-33 ADAM7 in induction of IL-13, mucus overproduction and chronic lung disease following viral infection [20••]. Finally, endogenous IL-33 has been found to be necessary for induction of potent CD8+ T cell responses

to replicating, prototypic RNA and DNA viruses in mice [21], indicating that IL-33 may play a role in type-1 immune responses under certain conditions. The crucial role of endogenous IL-33 in allergic inflammation was first demonstrated using IL-33-deficient mice [22]. IL-33 was found to be required for ovalbumin-induced and protease allergen (papain)-induced airway inflammation [22 and 23]. Further analyses revealed that IL-33 induces allergic airway inflammation by stimulating lung ILC2s [24, 25, 26 and 27•]. Indeed, papain-driven IL-5 and IL-13 production from ILC2s, eosinophilic lung inflammation and Th2 cell differentiation were all found to be impaired in intranasally challenged IL-33-deficient mice [26 and 27•]. IL-33/ST2 signaling was also required for IL-5 and IL-13 production by lung ILC2s, and airway eosinophilia following exposure to the clinically relevant fungal allergen Alternaria alternata [ 24] or the danger signal uric acid [ 28•]. IL-33 also appears to be important for allergic inflammation in other tissues (nasopharynx, skin). For instance, studies using IL-33-deficient mice have revealed the crucial role of IL-33 in the development of experimental allergic rhinitis induced by ragweed pollen [29••].